S. Zlotnick

发表

Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice

J. Kremer, D. Pappas, J. Best, 2019, Rheumatology and Therapy.

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

J. Kremer, D. Pappas, J. Best, 2021, Rheumatology and Therapy.

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study

J. Kremer, M. Greenwald, N. Gaylis, 2014, BMC Musculoskeletal Disorders.

P96 EFFECT OF OVER-THE-COUNTER DOSES OF NAPROXEN SODIUM ON INHIBITION OF PLATELET CYCLOOXYGENASE-1 IN HEALTHY VOLUNTEERS

M. Hochberg, R. Schuller, M. Schiff, 2006 .

Impact of naproxen sodium at over-the-counter doses on cyclooxygenase isoforms in human volunteers.

B. Hinz, K. Brune, O. Cheremina, 2008, International journal of clinical pharmacology and therapeutics.

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.

B. Lewis, G. Eisen, I. Gralnek, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis

J. Kremer, J. Greenberg, L. Harrold, 2017, Rheumatology and Therapy.

Celecoxib is associated with fewer small bowel lesions than naproxen+omeprazole in healthy subjects as determined by capsule endoscopy

B. Lewis, G. Eisen, I. Gralnek, 2003, American Journal of Gastroenterology.

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis

A Gibofsky, G. Koch, R. Moskowitz, 2004, Annals of the rheumatic diseases.

Effectiveness of Tocilizumab in Patients with Rheumatoid Arthritis Is Unaffected by Comorbidity Burden or Obesity: Data from a US Registry

J. Kremer, D. Pappas, J. Best, 2020, The Journal of Rheumatology.

A multiple‐dose safety and bioequivalence study of a narrow therapeutic index drug: A case for carbamazepine

E. Masson, B. Levitt, S. Zlotnick, 1999, Clinical pharmacology and therapeutics.

Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

J. Kremer, L. Harrold, J. Best, 2018, Rheumatology and Therapy.

SAT0196 Repeated rituximab infusions for the therapy of rheumatoid arthritis is not associated with increased rates of serious infections

J. Greenberg, J. Best, R. Magner, 2017 .

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

J. Kremer, D. Pappas, J. Best, 2020, Rheumatology and Therapy.

Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry

J. Kremer, J. Greenberg, L. Harrold, 2017, Clinical Rheumatology.

AB0407 Comparative effectiveness of tocilizumab (TCZ) monotherapy with tumor necrosis factor inhibitors (TNFI) in combination with varying doses of methotrexate (MTX) in patients with rheumatoid arthritis

J. Best, G. Persuitte, S. Zlotnick, 2017 .

Abnormal small bowel findings are common in healthy subjects screened for a multi-center, double blind, randomized, placebo-controlled trial using capsule endoscopy

B. Lewis, N. Arber, J. Johanson, 2003 .